Medicare Part D Leads: A Guide for Agents

Medicare Part D leads connect agents with seniors seeking standalone prescription drug coverage, distinct from Medicare Advantage plans that may bundle drug coverage in.

This category typically attracts prospects on Original Medicare needing separate drug coverage, along with some Medicare Advantage members whose current plan doesn't include the specific drug benefit they need.

Understanding the Part D Product

Part D plans specifically cover prescription drugs, appealing to Original Medicare beneficiaries who need this coverage added separately. Because Part D is optional but carries a late enrollment penalty for beneficiaries who go without creditable drug coverage, a meaningful share of shopping activity comes from people trying to avoid or resolve that penalty.

Common Triggers for This Category

New prescription needs, dissatisfaction with current drug coverage, and annual plan comparison shopping commonly trigger genuine Part D interest. A newly prescribed high-cost medication can single-handedly push someone to re-shop plans mid-year in search of a formulary that covers it more affordably, even outside the standard enrollment window through a Special Enrollment Period.

What Defines a Quality Part D Lead

• Genuine, current coverage shopping intent.
• Confirmed Original Medicare enrollment status.
• Documented, compliant consent for contact.
• Accurate, current contact information.

Explaining Formulary Coverage Clearly

Clearly explaining how a specific plan's drug formulary covers a prospect's actual medications helps build genuine, informed trust. Agents who walk through tier placement, whether a drug requires prior authorization or step therapy, and how costs change once a prospect enters the coverage gap tend to close more confidently than those who lead with premium price alone.

Understanding the Extra Help and Low-Income Subsidy Angle

A portion of Part D shoppers qualify for the federal Extra Help program, also called the Low-Income Subsidy, which reduces or eliminates premiums, deductibles, and copays for eligible beneficiaries. Agents working this category benefit from knowing the basic income and asset thresholds so they can flag potential eligibility and route prospects toward the right application process.

What Drives Cost Per Lead in This Category

Part D leads typically price below Medicare Advantage and Supplement leads given the smaller commission opportunity per enrollment, but exclusivity, confirmed Original Medicare status, and how recently the shopping intent was captured still move price. Leads tied to a specific triggering event, such as a new high-cost prescription, often convert at a higher rate than generic annual comparison shoppers.

How to Evaluate a Part D Lead Provider

• Do they confirm the prospect is on Original Medicare, not already on an MA plan with drug coverage?
• Is the shopping intent tied to a specific trigger, like a new prescription?
• How recently was the lead's consent and intent captured?
• Do they offer any targeting by known formulary or drug-tier concerns?

Timing Outreach Around AEP

Part D shopping concentrates heavily around the Annual Enrollment Period, making it worth planning outreach around this predictable seasonal surge.

Sourcing Through a Trusted Marketplace

Agents can source Medicare Part D leads through Eilite's buy leads platform alongside other Medicare formats.

Measuring Conversion for This Category

Tracking cost per enrollment helps agents confirm their lead sourcing is genuinely producing strong returns for this specific product.

What Part D Leads Typically Cost

Part D leads typically price toward the lower end of the Medicare lead spectrum, running roughly $6 to $15 per shared lead and $15 to $30 for an exclusive real-time lead, reflecting the smaller commission most carriers pay on a standalone drug plan compared to Advantage or Supplement business. Leads tied to a specific triggering event — a new high-cost prescription or a formulary change notice — sometimes command a modest premium over generic annual comparison leads, since that added context typically improves conversion enough to justify the higher price.

Explaining the Coverage Gap in Plain Terms

Part D plans move a beneficiary through several cost phases over the plan year: an initial deductible phase, an initial coverage phase where the plan and beneficiary share drug costs, a coverage gap phase often still referred to as the 'donut hole' even though recent reforms have narrowed its financial impact, and a catastrophic phase where out-of-pocket costs drop sharply once a beneficiary's spending crosses an annual threshold. Many prospects have heard the term 'donut hole' and worry about a large cost cliff without understanding how the phases actually work today. Walking through this progression concretely — using the prospect's actual medications to estimate roughly when they might move between phases over the year — tends to reduce anxiety and build far more credibility than a generic disclaimer about 'coverage phases' read off a script.

Standalone PDP vs. Medicare Advantage With Drug Coverage

A meaningful share of Part D shopping activity involves a prospect deciding between a standalone Part D plan paired with Original Medicare, or switching to a Medicare Advantage plan that bundles drug coverage in. The right answer depends on factors beyond just drug costs: provider network preferences, whether the prospect already has or wants a Medigap policy (which generally can't be paired with Medicare Advantage), and how much the prospect values the simplicity of one combined plan versus separate coverage they can each independently manage. Agents working Part D leads should be prepared to have this broader conversation rather than assuming every prospect has already ruled out Medicare Advantage, since a lead search for 'drug plan' sometimes really reflects a prospect still deciding on their overall Medicare structure.

A Practical Formulary Check Script

• Ask the prospect to list every current prescription, including dosage and frequency, not just drug names.
• Check each medication's tier placement on the plan being considered, and flag any requiring prior authorization or step therapy.
• Estimate the prospect's likely position in the coverage phases based on their total expected annual drug spend.
• Compare that estimate against at least one alternative plan so the prospect sees a real trade-off, not just one option.
• Confirm the prospect's preferred pharmacy is in-network, since out-of-network pharmacy costs can erase savings elsewhere.

When to Revisit a Part D Recommendation Mid-Year

A Part D recommendation that was accurate in January isn't guaranteed to stay right into December, since formularies and pharmacy networks can change during the plan year and a prospect's own prescriptions often change too. Agents who check in with existing Part D clients mid-year — after a new prescription, a pharmacy switch, or a notice from the carrier about a formulary change — can catch a mismatch early and, where a Special Enrollment Period applies, help the client move to better-fitting coverage before an otherwise avoidable cost surprise arrives.